Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Retinoblastoma 3Stomach Neoplasms 2Pancreatic Neoplasms 2Keratosis, Actinic 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinal Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Osteosarcoma 1Neuroblastoma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Esophageal Neoplasms 1Condylomata Acuminata 1Colorectal Neoplasms 1Colonic Neoplasms 1Appendiceal Neoplasms 1

Interventions

Bevacizumab 233Fluorouracil 219Oxaliplatin 215Irinotecan 215Leucovorin 198Capecitabine 153Cetuximab 145Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15apatinib 14Gemcitabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × Cryotherapy × Clear all
NCT03524274 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡